SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-env...
Surgeons are concerned about the cost of breast matrices in an increasingly restrictive environment, but...
Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under...
CMS Reimbursement changes raging like a beast to belabor several HA market players For Q322, the true im...
As the CEO of SmartTRAK, I understand Medtech executives often drown in data and need quick, easy access...
SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentiall...
Even stronger foreign exchange headwinds inhibit revenue growth from steadily improving elective procedu...
Do you love keeping up with the latest trends in the Spine and OrthoBiologics/Regen medicine markets? Ar...
The potential of US reimbursement changes to Skin Substitutes weighed heavily on companies at SAWC Fall,...
In the market for Trauma & Extremities, companies continue to innovate with new product introduction...
Login